BioElectronics Corporation

OTCPK:BIEL Stock Report

Market Cap: US$4.9m

BioElectronics Past Earnings Performance

Past criteria checks 0/6

No hay datos suficientes sobre los resultados de BioElectronics en los últimos años.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth raten/a
Return on equityn/a
Net Marginn/a
Last Earnings Update31 Dec 2021

Recent past performance updates

No updates

Recent updates

In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, BioElectronics has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.

Show section

Revenue & Expenses Breakdown
Beta

How BioElectronics makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:BIEL Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 212010
30 Sep 212010
30 Jun 212-110
31 Mar 211-110
31 Dec 201-110
30 Sep 201-210
30 Jun 201-211
31 Mar 201-211
31 Dec 191-211
30 Sep 191-321
30 Jun 191-311
31 Mar 191-320
31 Dec 181-320
30 Sep 181-321
30 Jun 182-220
31 Mar 182-220
31 Dec 172-220
30 Sep 172-220
30 Jun 172-220
31 Mar 172-220
31 Dec 162-220
30 Sep 162-220
30 Jun 162-220
31 Mar 162-220
31 Dec 152-221
30 Sep 152-320
30 Jun 152-320
31 Mar 152-320
31 Dec 141-320
30 Sep 141-320
30 Jun 141-320
31 Mar 141-320
31 Dec 131-220
30 Sep 131-220
30 Jun 130-220

Beneficios de calidad: Datos insuficientes para determinar si BIEL tiene ganancias de alta calidad.

Creciente margen de beneficios: No hay datos suficientes para determinar si los márgenes de beneficio de BIEL han mejorado en el último año.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Tendencia de beneficios: No hay datos suficientes para determinar si la tasa de crecimiento interanual de los beneficios de BIEL ha sido positiva en los últimos 5 años.

Acelerando crecimiento: No hay datos suficientes para comparar el crecimiento de los beneficios del último año de BIEL con su media de 5 años.

Beneficios vs. Industria: Datos insuficientes para determinar si el crecimiento de los beneficios de BIEL en el último año superó la media del sector Medical Equipment.


Return on Equity

Alto ROE: BIEL tiene un Rendimiento de los fondos propios negativo (0%), ya que actualmente no es rentable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.